In conclusion, prostate cancer survivors diagnosed with asymptomatic PSA-detected disease were at lower risk of depression, anxiety and stress during survivorship than those with symptomatic clinically diagnosed disease, following adjustment for socio-demographic and clinical factors. The gene discussed is KLK3; the disease is depressive symptom measurement.